Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study

Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study

Background: Despite the increasing interest in biologics for the management of allergic diseases, sparse real-world data are still available in the pediatric population. This study aimed to evaluate the early real-life efficacy and safety of omalizumab for patients with moderate-to-severe asthma and...

Full description

Bibliographic Details
Main Authors: Lucia Caminiti, Francesca Galletta, Simone Foti Randazzese, Paolo Barraco, Stefano Passanisi, Antonella Gambadauro, Giuseppe Crisafulli, Mariella Valenzise, Sara Manti
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Children
Subjects:
atopic dermatitis
asthma
chronic urticaria
dupilumab
efficacy
omalizumab
Online Access:https://www.mdpi.com/2227-9067/11/2/170

Internet

https://www.mdpi.com/2227-9067/11/2/170

Similar Items